Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nihon Chouzai Co ( (JP:3341) ) has shared an announcement.
Nihon Chouzai Co., Ltd. announced corrections to its previously released consolidated financial results for the fiscal year ended March 31, 2025, and its operations forecast for the fiscal year ending March 31, 2026. The corrections involve adjustments to the EBITDA figures, impacting the company’s financial projections and potentially affecting stakeholder expectations.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates within the pharmaceutical industry, focusing on providing pharmacy services and related healthcare solutions in Japan. The company is listed on the Tokyo Stock Exchange Prime Market.
Average Trading Volume: 306,922
Technical Sentiment Signal: Buy
Current Market Cap: Yen86.5B
Learn more about 3341 stock on TipRanks’ Stock Analysis page.